ANVU | NCT06476639

The ANVU trial aims to determine whether groin ultrasound monitoring (1) is effective and safe to replace invasive groin LND to manage vulvar cancer; (2) decreases the morbidity associated with vulvar cancer surgery; and (3) is cost-effective.

ANVU | NCT064766392026-03-12T21:02:24+11:00

STRIVE/VU.2 | NCT06358469

Primary Objective - To estimate the 3-year local recurrence rates in patients with HPV-A and HPV-I VSCC surgically managed based on dVIN/p53 status and tumour margin clearance.

STRIVE/VU.2 | NCT063584692026-03-12T21:02:36+11:00

EN.10/TAPER | NCT05640999

The primary objective of this study is to estimate the rate of pelvic recurrence at 3 years in patients who are treated with de-escalated adjuvant treatment directed by tumour molecular status.

EN.10/TAPER | NCT056409992026-03-12T21:02:55+11:00
Go to Top